Lance Clouse, APRN
Family · van Buren, ARNPI 1740249523
Payments from drug & device makers
Across 96 payments — averaging $14.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$538
- Amgen$412
- Otsuka America Pharmaceutical, Inc.$105
- Antares Pharma, Inc.$87
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$82
- Biohaven Pharmaceutical Holding Company Ltd.$54
- plus $69 from 4 others
What the payments were for
- Food & beverage$1,30097%
- Education$473%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 52 | $538 |
| Amgen | 24 | $412 |
| Otsuka America Pharmaceutical, Inc. | 5 | $105 |
| Antares Pharma, Inc. | 5 | $87 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $82 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $54 |
| Kowa Pharmaceuticals America, Inc. | 1 | $28 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Halozyme Inc | 1 | $13 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
How this compares
$1,347 in reported general payments places this provider in the 70th percentile of 2,103 family providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 12 | $2,158 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $1,977 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 84 | $1,265 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 49 | $1,124 |
| Testosterone Cypionate | 31 | $1,038 |
| Celecoxib | 46 | $884 |
| ProgesteroneProgesterone, Micronized | 37 | $855 |
| Ventolin HfaAlbuterol Sulfate | 15 | $843 |
| Gabapentin | 87 | $807 |
| Levothyroxine Sodium | 110 | $718 |
| Tamsulosin Hcl | 68 | $714 |
| Nifedipine ErNifedipine | 20 | $616 |
| Tizanidine Hcl | 63 | $472 |
| Omeprazole | 51 | $438 |
| FenofibrateFenofibrate Nanocrystallized | 15 | $412 |
Paid to pharmacies, not to this prescriber.
Other family in van Buren
- Leah CarringtonRogers$1.6M
- Nina CopelandFort Smith$207K
- Stefanie BrackinJonesboro$51K
- Amanda DavisFort Smith$46K
- Allison HittManila$40K
- Kimberly GatesNorth Little Rock$31K
- Meghan MallettConway$25K
- Anthony EcholsLittle Rock$25K
- Shelby CochranFayetteville$23K
- Michael StirlingLittle Rock$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.